Maternal and Postnatal Effects of Poly I:C‐Induced Intrauterine Inflammation and Rytvela, a Non‐Competitive IL‐1R Antagonist, in the Pregnant Spiny Mouse

Maternal infection-induced inflammation during pregnancy is associated with adverse neurodevelopment. Rytvela, an allosteric IL-1 receptor antagonist, reduces IL-1β-mediated pathology in fetal rodents and sheep. However, its effects on TLR3-mediated inflammation and subsequent offspring growth and behavior remain unclear. Using precocial spiny mice, the primary outcome of this study was to examine whether rytvela could attenuate the acute maternal inflammatory response to mid-gestation exposure to polyinosinic:polycytidylic acid (Poly(I:C)). Secondary offspring outcomes included postnatal growth and behavior. At gestational day 20 (term = 39 days), pregnant mice received two intraperitoneal injections, 4 h apart, of saline (0.9% w/v, n = 14), Poly(I:C) (12 mg/kg, n = 14), or Poly(I:C) + rytvela (12 mg/kg + 3 mg/kg, respectively, n = 14). Ten dams/group were culled 8 h after dose 1 to assess inflammatory responses. The remainder (n = 4 dams/group) were delivered at term. Offspring (control n = 7, Poly(I:C) n = 8, Poly(I:C) + rytvela n = 11) growth was monitored and behavioral testing undertaken from postnatal day (PND) 3-45. Poly(I:C) increased maternal serum (p = 0.01) and amniotic fluid (p = 0.003) IL-1β, and upregulated Il1b, Il6 and Tnf expression in the spleen and thymus. Rytvela reduced IL-1β levels but did not attenuate elevated cytokine gene expression. Poly(I:C) slowed postnatal growth (PND 18-27, p < 0.05), which recovered earlier with rytvela. Poly(I:C) exposure did not alter offspring behavior in tests completed to PND 45. However, Poly(I:C) + rytvela offspring showed reduced locomotor activity (distance: p < 0.001; velocity: p = 0.021). In conclusion, rytvela attenuated the primary inflammatory response to Poly(I:C), promoting earlier postnatal growth recovery despite persistent cytokine gene expression. Reduced locomotor activity after prenatal rytvela exposure warrants further investigation.

Authors

Institutions

Publication Details

Journal
Developmental Neurobiology
Published
2026-09-17
DOI
https://doi.org/10.1002/dneu.70064
Primary Topic
Reproductive System and Pregnancy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Maternal and Postnatal Effects of Poly I:C‐Induced Intrauterine Inflammation and Rytvela, a Non‐Competitive IL‐1R Antagonist, in the Pregnant Spiny Mouse

Sylvain Chemtob, Nadia Bellofiore, Rachid Kamareddine, Jeffrey A. Keelan et al.
Developmental Neurobiology
Reproductive System and Pregnancy
article

Maternal and Postnatal Effects of Poly I:C‐Induced Intrauterine Inflammation and Rytvela, a Non‐Competitive IL‐1R Antagonist, in the Pregnant Spiny Mouse

Sylvain Chemtob, Nadia Bellofiore, Rachid Kamareddine, Jeffrey A. Keelan, Stacey J. Ellery, David M. Olson, Sarah A. Robertson, Nhi T. Tran
article en

Abstract

Maternal infection-induced inflammation during pregnancy is associated with adverse neurodevelopment. Rytvela, an allosteric IL-1 receptor antagonist, reduces IL-1β-mediated pathology in fetal rodents and sheep. However, its effects on TLR3-mediated inflammation and subsequent offspring growth and behavior remain unclear. Using precocial spiny mice, the primary outcome of this study was to examine whether rytvela could attenuate the acute maternal inflammatory response to mid-gestation exposure to polyinosinic:polycytidylic acid (Poly(I:C)). Secondary offspring outcomes included postnatal growth and behavior. At gestational day 20 (term = 39 days), pregnant mice received two intraperitoneal injections, 4 h apart, of saline (0.9% w/v, n = 14), Poly(I:C) (12 mg/kg, n = 14), or Poly(I:C) + rytvela (12 mg/kg + 3 mg/kg, respectively, n = 14). Ten dams/group were culled 8 h after dose 1 to assess inflammatory responses. The remainder (n = 4 dams/group) were delivered at term. Offspring (control n = 7, Poly(I:C) n = 8, Poly(I:C) + rytvela n = 11) growth was monitored and behavioral testing undertaken from postnatal day (PND) 3-45. Poly(I:C) increased maternal serum (p = 0.01) and amniotic fluid (p = 0.003) IL-1β, and upregulated Il1b, Il6 and Tnf expression in the spleen and thymus. Rytvela reduced IL-1β levels but did not attenuate elevated cytokine gene expression. Poly(I:C) slowed postnatal growth (PND 18-27, p < 0.05), which recovered earlier with rytvela. Poly(I:C) exposure did not alter offspring behavior in tests completed to PND 45. However, Poly(I:C) + rytvela offspring showed reduced locomotor activity (distance: p < 0.001; velocity: p = 0.021). In conclusion, rytvela attenuated the primary inflammatory response to Poly(I:C), promoting earlier postnatal growth recovery despite persistent cytokine gene expression. Reduced locomotor activity after prenatal rytvela exposure warrants further investigation.

Developmental NeurobiologyVol. 86(4)
University of Alberta (CA), The University of Western Australia (AU), Centre Hospitalier Universitaire Sainte-Justine (CA), Hudson Institute of Medical Research (AU), University of Alberta Hospital (CA), Monash University (AU), The University of Adelaide (AU), Monash Institute of Medical Research (AU)
National Health and Medical Research Council
Good health and well-being
Openalex Percentile: Top 17%
Reproductive System and Pregnancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.